je.st
news
Tag: highlight
Free webinar to highlight the processing of common food ingredients
2017-08-02 18:40:13| Canadian Plastics Headlines
On Wednesday, August 9 at 2 pm, Hosokawa Micron Powder Systems will be hosting a free webinar that will focus on processing seven common food materials. The post Free webinar to highlight the processing of common food ingredients appeared first on Canadian Plastics.
Tags: free
food
common
processing
PPG Experts, Industry Partners to Highlight New Automotive Technologies at SURCAR Cannes Congress
2017-06-20 19:16:00| Coatings World Breaking News
Tags: industry
partners
automotive
technologies
STEADY REVENUE GROWTH, PROFIT HIGHLIGHT RES' FIRST 5 YEARS
2017-06-19 12:08:31| Carrier Hotels
SACRAMENTO, California (July 11, 2005) - RagingWire Enterprise Solutions, Inc. (RES), a leading IT outsourcing provider of software as a service and on-demand solutions, today announced the company has averaged 94 percent revenue growth and 256 percent average client...
Researchers Highlight Alarming Link Between Feral Pigs and Vampire Bats
2017-02-07 01:00:00| ThePigSite - Industry News
BRAZIL - The number of vampire bats, which transmit rabies and are a concern for livestock breeders, may be increasing in Brazil and the Americas along with growth in the populations of invasive feral pigs and wild boars (Sus scrofa).
Tags: link
researchers
highlight
vampire
New KEYTRUDA (pembrolizumab) Data to be Presented at 17th World Conference on Lung Cancer Highlight Research Across the Spectrum of Thoracic Malignancies
2016-11-30 13:00:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. Findings to be Presented in Non-Small Cell Lung Cancer, Small Cell Lung Cancer and Malignant Pleural Mesothelioma with KEYTRUDA as Monotherapy and in Combination with Other Treatments Quality of Life Data from KEYNOTE-024 in First-Line Non-Small Cell Lung Cancer to be Presented in Plenary Session KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that new data investigating the use of KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, across multiple thoracic malignancies, including non-small cell lung cancer (NSCLC), small cell lung cancer and malignant pleural mesothelioma, will be presented at the 17th World Conference on Lung Cancer (WCLC) hosted by the International Association for the Study of Lung Cancer in Vienna, Austria, Dec. Language: English Contact: Media Contacts:Pamela Eisele, (267) 305-3558orKim Hamilton, (908) 740-1863orInvestor Contacts:Teri Loxam, (908) 740-1986orAmy Klug, (908) 740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Sites : [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] next »